Pharmeasy parent enters unicorn club at $1.5 billion valuation
SECTIONS
Share
Synopsis
Pharmeasy’s $350 million funding round comes at a time when Reliance, Tata Group and Amazon are looking to tap the online pharmacy business by way of acquisitions.
ETtech
Pharmaeasy is the seventh startup unicorn this year, after Cred, Meesho, Digit Insurance, Innovaccer, Infra.Market and Five Star Finance. (Illustration: Rahul Awasthi/ETtech)
Bengaluru: Prosus Ventures and US-based private equity firm TPG Capital are leading an investment of $350 million (about Rs 2,570 crore) in API Holdings, the parent company of Mumbai-based online pharmacy Pharmeasy.
Prosus Ventures (previously Naspers Ventures) is the venture investing arm of South African technology and media conglomerate Prosus, which is one of the largest investors in Indian technology startups including Swiggy, Byju s and Meesho.
Alkem makes epilepsy treatment more accessible & affordable with the launch of Brivasure (Brivaracetam)
equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.
Alkem unveils affordable epilepsy drug
thehindu.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindu.com Daily Mail and Mail on Sunday newspapers.